Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be reporting earnings this Tuesday after market close. Here’s what ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first ...
Cancer isn't a static target. Its genetic profile can change. So even with the newer targeted therapies, a patient's care ...
Full-year 2026 revenue guidance is reiterated at $350 million, assuming the $53 million contribution from recent acquisitions will partially or fully offset the decline from the largest customer.
During the early stages of a pandemic, viruses tend to evolve in ways that enhance their ability to reproduce and spread, ...
In Mendelian inheritance patterns, you receive one version of a gene, called an allele, from each parent. These alleles can be dominant or recessive. Non-Mendelian genetics don’t completely follow ...
Opus Genetics, Inc. (NASDAQ:IRD) is one of the best performing small cap stocks so far in 2026. On April 28, Citizens ...
​​The absolute driver behind this youth explosion is a drastic shift in how we live. Urbanization wiped out physical activity. Young professionals sit at desks for ten hours, endure stressful commutes ...
All the latest content about Genetics from the BBC.